← FDA DRUG APPROVALS

FDA ANDA · ANDA074969

ACYCLOVIR SODIUM

Sponsor: TEVA PARENTERAL

APPLICATION
ANDA074969
TYPE
ANDA
ORIGINAL APPROVAL
1997-08-26
LATEST ACTION
2002-07-09
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ACYCLOVIR SODIUMDiscontinued
ACYCLOVIR SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
ACYCLOVIR SODIUMDiscontinued
ACYCLOVIR SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2002-07-09Labeling · Supplement 4AP
2002-02-01Labeling · Supplement 3AP
2000-06-09Labeling · Supplement 2AP
1999-03-22Manufacturing (CMC) · Supplement 1AP
1997-08-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →